Showcasing the company's strong development confidence and safeguarding the long-term interests of shareholders, LEON INSPECTION (01586) has accumulated a repurchase of 3,344,000 shares over 8 consecutive trading days, totaling 6.6494 million Hong Kong dollars.
In recent period, Lihong Inspection (01586) has been continuously buying back its own shares. On December 24th, Lihong Inspection spent approximately 1.4 million Hong Kong dollars to buy back 704,000 shares.
Recently, LEON INSPECTION (01586) has been continuously buying back its shares. On December 24th, LEON INSPECTION spent approximately 1.4 million Hong Kong dollars to buy back 704,000 shares. The company has been conducting buybacks for 8 consecutive trading days since December 13th, with a total of 3.344 million shares bought back, amounting to approximately 6.6494 million Hong Kong dollars. These buyback actions not only demonstrate the company's recognition of its own value, but also convey optimistic expectations for future development and a belief in protecting the long-term interests of shareholders.
According to the mid-term report of LEON INSPECTION, the company's performance is steadily improving. The company's performance for the six months ending on June 30, 2024, showed that the group achieved revenue of 612 million Hong Kong dollars, an increase of 21.08% compared to the same period. The attributable profit to company owners was 50.828 million Hong Kong dollars, a 5.26% increase compared to the same period. The basic earnings per share were 9.62 Hong Kong cents.
Related Articles

HK Stock Market Move | SICC Co., Ltd. (02631) rose more than 8%, and silicon carbide became the new route for chip cooling. The company is a leading enterprise in silicon carbide substrates.

HK Stock Market Move | AKESO(09926) rose nearly 3% in early trading. Recently, the CD47 Lafflet single antibody was granted FDA orphan drug status.

New stock first day | Kingway Pharmaceuticals-B (02595) debuted on the market with an opening increase of 115.79% in the morning session. Its core product GFH925 has already been commercialized domestically.
HK Stock Market Move | SICC Co., Ltd. (02631) rose more than 8%, and silicon carbide became the new route for chip cooling. The company is a leading enterprise in silicon carbide substrates.

HK Stock Market Move | AKESO(09926) rose nearly 3% in early trading. Recently, the CD47 Lafflet single antibody was granted FDA orphan drug status.

New stock first day | Kingway Pharmaceuticals-B (02595) debuted on the market with an opening increase of 115.79% in the morning session. Its core product GFH925 has already been commercialized domestically.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025